Evidence map›Paper›PMID 32788728›Full record

ArticleNature2020

Structure of the essential inner membrane lipopolysaccharide-PbgA complex.

Thomas Clairfeuille, Kerry R Buchholz, Qingling Li, Erik Verschueren, Peter Liu, Dewakar Sangaraju, Summer Park, Cameron L Noland, Kelly M Storek, Nicholas N Nickerson and 19 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Crystal Structure of Periplasmic Domain of YejM fromJournal of microbiology and biotechnology · 2026
    Article
  9. Article
  10. Article
  11. Exquisite specificity of Pks13 defines the essentiality of trehalose in mycobacteria.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Rational Design of Natural Xanthones Against Gram-negative Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  18. A periplasmic protein modulates the proteolysis of peptidoglycan hydrolases to maintain cell wall homeostasis inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 4 institutions in 2 countries.

Thomas Clairfeuille *Structural Biology, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4763-8928
Kerry R Buchholz *Infectious Diseases, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9419-0076
Qingling LiMicrochemistry, Proteomics & Lipidomics, Genentech Inc., South San Francisco, CA, USA.
Erik VerschuerenMicrochemistry, Proteomics & Lipidomics, Genentech Inc., South San Francisco, CA, USA.
Peter LiuMicrochemistry, Proteomics & Lipidomics, Genentech Inc., South San Francisco, CA, USA.
Dewakar SangarajuDrug Metabolism & Pharmacokinetics, Genentech Inc., South San Francisco, CA, USA.
Summer ParkTranslational Immunology, Genentech Inc., South San Francisco, CA, USA.
Cameron L NolandStructural Biology, Genentech Inc., South San Francisco, CA, USA.
Kelly M StorekInfectious Diseases, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2289-0214
Nicholas N NickersonInfectious Diseases, Genentech Inc., South San Francisco, CA, USA.
Lynn MartinBioMolecular Resources, Genentech Inc., South San Francisco, CA, USA.
Trisha Dela VegaBioMolecular Resources, Genentech Inc., South San Francisco, CA, USA.
Anh MiuBiochemical & Cellular Pharmacology, Genentech Inc., South San Francisco, CA, USA.
Janina ReederBioinformatics & Computational Biology, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6704-6754
Maria Ruiz-GonzalezDiscovery Chemistry Departments, Genentech Inc., South San Francisco, CA, USA.
Danielle SwemInfectious Diseases, Genentech Inc., South San Francisco, CA, USA.
Guanghui HanMicrochemistry, Proteomics & Lipidomics, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9893-9168
Daniel P DePonteLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA, USA.
Mark S HunterLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA, USA.ORCID http://orcid.org/0000-0002-0110-7075
Cornelius GatiBioscience Division, SLAC National Accelerator Laboratory, Menlo Park, CA, USA.ORCID http://orcid.org/0000-0003-3693-7009
Sheerin Shahidi-LathamDrug Metabolism & Pharmacokinetics, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2773-4325
Min XuTranslational Immunology, Genentech Inc., South San Francisco, CA, USA.
Nicholas SkeltonDiscovery Chemistry Departments, Genentech Inc., South San Francisco, CA, USA.
Benjamin D SellersDiscovery Chemistry Departments, Genentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-4194-1240
Elizabeth SkippingtonBioinformatics & Computational Biology, Genentech Inc., South San Francisco, CA, USA.
Wendy SandovalMicrochemistry, Proteomics & Lipidomics, Genentech Inc., South San Francisco, CA, USA.
Emily J HananDiscovery Chemistry Departments, Genentech Inc., South San Francisco, CA, USA. hanan.emily@gene.com.ORCID http://orcid.org/0000-0001-7681-9424
Jian PayandehStructural Biology, Genentech Inc., South San Francisco, CA, USA. payandeh.jian@gene.com.ORCID http://orcid.org/0000-0002-4015-9716
Steven T RutherfordInfectious Diseases, Genentech Inc., South San Francisco, CA, USA. rutherford.steven@gene.com.ORCID http://orcid.org/0000-0002-4758-4248
SLAC National Accelerator Laboratory · USGene Therapy Laboratory · FRSunesis (United States) · USGenVec · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharide (LPS) resides in the outer membrane of Gram-negative bacteria where it is responsible for barrier function

Indexed as

AmidohydrolasesAmino Acid MotifsBacterial Outer MembraneBinding SitesCell MembraneEnzyme StabilityEscherichia coliEscherichia coli ProteinsGenes, EssentialHydrolasesLipid ALipopolysaccharidesMicrobial Sensitivity TestsMicrobial ViabilityModels, MolecularPeptide FragmentsAmidohydrolasesEscherichia coli ProteinsHydrolasesLipid ALipopolysaccharidesPeptide FragmentsUDP-3-O-acyl-N-acetylglucosamine deacetylaseYejM protein, E coli

Identifiers

PMID32788728
OpenAlexW3048448785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.